Lauren Rusckowski Duprey insider trades
Open-market stock purchases and sales by Lauren Rusckowski Duprey, Chief Transformation Officer at Takeda Pharmaceutical Co Ltd, from SEC Form 4 filings since Apr 27, 2026.
Companies traded
- TAK Takeda Pharmaceutical Co Ltd: 1 sale, last Sep 14, 2026
Get free alerts when Lauren Rusckowski Duprey files a new trade →